Preoperative risk reduction. Strategies to optimize outcomes.

Surgical Clinics of North America

Volumn 93, Issue 5, 2013, Pages 1041-1055

  Martindale, Robert G ^a   Deveney, Clifford W ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hernia repair; Intervention; Obesity; Perioperative morbidity; Surgical site infection

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CHLORHEXIDINE; GLUCOSE; IODINE; NICOTINE PATCH; POVIDONE IODINE; PSEUDOMONIC ACID; TRICLOSAN; VANCOMYCIN;

ABDOMINAL WALL HERNIA; ANTIBIOTIC PROPHYLAXIS; BLOOD GLUCOSE MONITORING; BODY MASS; CARBOHYDRATE DIET; COST EFFECTIVENESS ANALYSIS; DIARRHEA; HOSPITALIZATION; HUMAN; INCISIONAL HERNIA; METABOLIC REGULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORBIDITY; NOSE; NUTRITIONAL SUPPORT; OBESITY; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SAFETY; SKIN; SMOKING CESSATION; STOMACH BYPASS; SURGICAL INFECTION; SURGICAL MESH; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

HERNIA REPAIR; INTERVENTION; OBESITY; PERIOPERATIVE MORBIDITY; SURGICAL SITE INFECTION;

ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; DIET; HERNIA, VENTRAL; HUMANS; HYPERGLYCEMIA; NUTRITIONAL SUPPORT; OBESITY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RECURRENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION; SURGICAL WOUND INFECTION;

EID: 84883781562     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2013.06.015     Document Type: Review

References (103)

1. Flum D.R., Horvath K., Koepsell T. Have outcomes of incisional hernia repair improved with time? A population-based analysis. Ann Surg 2003, 237(1):129-135.
2. Sanchez V.M., Abi-Haidar Y.E., Itani K.M. Mesh infection in ventral incisional hernia repair: incidence, contributing factors, and treatment. Surg Infect (Larchmt) 2011, 12(3):205-210.
3. Hawn M.T., Gray S.H., Snyder C.W., et al. Predictors of mesh explantation after incisional hernia repair. Am J Surg 2011, 202(1):28-33.
4. Eisen D.B. Surgeon's garb and infection control: what's the evidence?. JAm Acad Dermatol 2011, 64(5). 960.e1-20.
5. Jensen J.A., Goodson W.H., Hopf H.W., et al. Cigarette smoking decreases tissue oxygen. Arch Surg 1991, 126(9):1131-1134.
6. Knuutinen A., Kokkonen N., Risteli J., et al. Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br J Dermatol 2002, 146(4):588-594.
7. Sorensen L.T., Toft B.G., Rygaard J., et al. Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery 2010, 148(5):982-990.
8. Chang D.W., Reece G.P., Wang B., et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg 2000, 105(7):2374-2380.
9. Mallon W.J., Misamore G., Snead D.S., et al. The impact of preoperative smoking habits on the results of rotator cuff repair. JShoulder Elbow Surg 2004, 13(2):129-132.
10. Sorensen L.T., Hemmingsen U., Kallehave F., et al. Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg 2005, 241(4):654-658.
11. Sorensen L.T., Horby J., Friis E., et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002, 28(8):815-820.
12. Finan K.R., Vick C.C., Kiefe C.I., et al. Predictors of wound infection in ventral hernia repair. Am J Surg 2005, 190(5):676-681.
13. Yang G.P., Longaker M.T. Abstinence from smoking reduces incisional wound infection: a randomized, controlled trial. Ann Surg 2003, 238(1):6-8.
14. Lindstrom D., Sadr Azodi O., Wladis A., et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008, 248(5):739-745.
15. Sorensen L.T., Karlsmark T., Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003, 238(1):1-5.
16. Morimoto N., Takemoto S., Kawazoe T., et al. Nicotine at a low concentration promotes wound healing. JSurg Res 2008, 145(2):199-204.
17. Sorensen L.T., Jorgensen L.N., Zillmer R., et al. Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers. Wound Repair Regen 2006, 14(3):247-251.
18. Moller A.M., Villebro N., Pedersen T., et al. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002, 359(9301):114-117.
19. Kuri M., Nakagawa M., Tanaka H., et al. Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005, 102(5):892-896.
20. Manchio J.V., Litchfield C.R., Sati S., et al. Duration of smoking cessation and its impact on skin flap survival. Plast Reconstr Surg 2009, 124(4):1105-1117.
21. Mills E., Eyawo O., Lockhart I., et al. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011, 124(2):144-154.e8.
22. Sorensen L.T., Hemmingsen U.B., Kirkeby L.T., et al. Smoking is a risk factor for incisional hernia. Arch Surg 2005, 140(2):119-123.
23. Martindale R.G., McClave S.A., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: executive summary. Crit Care Med 2009, 37(5):1757-1761.
24. Daley J., Khuri S.F., Henderson W., et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the national veterans affairs surgical risk study. JAm Coll Surg 1997, 185(4):328-340.
25. Kudsk K.A., Tolley E.A., DeWitt R.C., et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr 2003, 27(1):1-9.
26. Munroe C., Frantz D., Martindale R.G., et al. The optimal lipid formulation in enteral feeding in critical illness: clinical update and review of the literature. Curr Gastroenterol Rep 2011, 13(4):368-375.
27. Jie B., Jiang Z.M., Nolan M.T., et al. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition 2012, 28(10):1022-1027.
28. Kondrup J., Rasmussen H.H., Hamberg O., et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003, 22(3):321-336.
29. Gianotti L., Braga M., Nespoli L., et al. Arandomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002, 122(7):1763-1770.
30. Braga M., Gianotti L., Vignali A., et al. Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. Nutrition 2005, 21(11-12):1078-1086.
31. Braga M., Gianotti L., Nespoli L., et al. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002, 137(2):174-180.
32. Braga M. Perioperative immunonutrition and gut function. Curr Opin Clin Nutr Metab Care 2012, 15(5):485-488.
33. Drover J.W., Dhaliwal R., Weitzel L., et al. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. JAm Coll Surg 2011, 212(3):385-399. 399.e1.
34. Pluess T.T., Hayoz D., Berger M.M., et al. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007, 33(5):789-797.
35. Calder P.C. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011, 668(Suppl 1):S50-S58.
36. Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br J Clin Pharmacol 2013, 75(3):645-662.
37. Lee H.N., Surh Y.J. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochem Pharmacol 2012, 84(10):1340-1350.
38. Calder P.C. Mechanisms of action of (n-3) fatty acids. JNutr 2012, 142(3):592S-599S.
39. Spite M., Norling L.V., Summers L., et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 2009, 461(7268):1287-1291.
40. Marik P.E., Flemmer M. The immune response to surgery and trauma: implications for treatment. JTrauma Acute Care Surg 2012, 73(4):801-808.
41. Rudolph F.B., Van Buren C.T. The metabolic effects of enterally administered ribonucleic acids. Curr Opin Clin Nutr Metab Care 1998, 1(6):527-530.
42. Burden S., Todd C., Hill J., et al. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev 2012, (11). CD008879.
43. Svanfeldt M., Thorell A., Hausel J., et al. Effect of "preoperative" oral carbohydrate treatment on insulin action-a randomised cross-over unblinded study in healthy subjects. Clin Nutr 2005, 24(5):815-821.
44. Soop M., Nygren J., Myrenfors P., et al. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab 2001, 280(4):E576-E583.
45. Fearon K.C., Ljungqvist O., Von Meyenfeldt M., et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005, 24(3):466-477.
46. Awad S., Constantin-Teodosiu D., Constantin D., et al. Cellular mechanisms underlying the protective effects of preoperative feeding: a randomized study investigating muscle and liver glycogen content, mitochondrial function, gene and protein expression. Ann Surg 2010, 252(2):247-253.
47. Awad S., Fearon K.C., Macdonald I.A., et al. Arandomized cross-over study of the metabolic and hormonal responses following two preoperative conditioning drinks. Nutrition 2011, 27(9):938-942.
48. Maung A.A., Davis K.A. Perioperative nutritional support: immunonutrition, probiotics, and anabolic steroids. Surg Clin North Am 2012, 92(2):273-283. viii.
49. Houck J.P., Rypins E.B., Sarfeh I.J., et al. Repair of incisional hernia. Surg Gynecol Obstet 1989, 169(5):397-399.
50. Cevasco M., Itani K.M. Ventral hernia repair with synthetic, composite, and biologic mesh: characteristics, indications, and infection profile. Surg Infect (Larchmt) 2012, 13(4):209-215.
51. Le D., Deveney C.W., Martindale R.G., et al. Mesh choice in ventral hernia repair. Am J Surg 2013, 205(5):602-607.
52. Rios A., Rodriguez J.M., Munitiz V., et al. Antibiotic prophylaxis in incisional hernia repair using a prosthesis. Hernia 2001, 5(3):148-152.
53. Bratzler D.W., Dellinger E.P., Olsen K.M., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013, 14(1):73-156.
54. Junker T., Mujagic E., Hoffmann H., et al. Prevention and control of surgical site infections: review of the Basel Cohort Study. Swiss Med Wkly 2012, 142:w13616.
55. Enzler M.J., Berbari E., Osmon D.R. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2011, 86(7):686-701.
56. Berbari E.F., Osmon D.R., Lahr B., et al. The Mayo Prosthetic Joint Infection Risk Score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 2012, 33(8):774-781.
57. Bratzler D.W., Houck P.M., Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004, 38(12):1706-1715.
58. Suehiro T., Hirashita T., Araki S., et al. Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery. Hepatogatsroenterology 2008, 55(86-87):1636-1639.
59. Fonseca S.N., Kunzle S.R., Junqueira M.J., et al. Implementing 1-dose antibiotic prophylaxis for prevention of surgical site infection. Arch Surg 2006, 141(11):1109-1113. [discussion: 1114].
60. Hanley M.J., Abernethy D.R., Greenblatt D.J. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010, 49(2):71-87.
61. Ventral Hernia Working Group, Breuing K., Butler C.E., et al. Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 2010, 148(3):544-558.
62. Dunne J.R., Malone D.L., Tracy J.K., et al. Abdominal wall hernias: risk factors for infection and resource utilization. JSurg Res 2003, 111(1):78-84.
63. Blatnik J.A., Krpata D.M., Novitsky Y.W., et al. Does a history of wound infection predict postoperative surgical site infection after ventral hernia repair?. Am J Surg 2012, 203(3):370-374. [discussion: 374].
64. Lin H.J., Spoerke N., Deveney C., et al. Reconstruction of complex abdominal wall hernias using acellular human dermal matrix: a single institution experience. Am J Surg 2009, 197(5):599-603. [discussion: 603].
65. Kiedrowski M.R., Horswill A.R. New approaches for treating staphylococcal biofilm infections. Ann N Y Acad Sci 2011, 1241:104-121.
66. Bull A.L., Worth L.J., Richards M.J. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive Staphylococcus aureus surgical site infections: report from Australian surveillance data (VICNISS). Ann Surg 2012, 256(6):1089-1092.
67. Diaz J.J., Conquest A.M., Ferzoco S.J., et al. Multi-institutional experience using human acellular dermal matrix for ventral hernia repair in a compromised surgical field. Arch Surg 2009, 144(3):209-215.
68. Dronge A.S., Perkal M.F., Kancir S., et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006, 141(4):375-380. [discussion: 380].
69. Turina M., Fry D.E., Polk H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005, 33(7):1624-1633.
70. Van Den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. NEngl J Med 2001, 345(19):1359-1367.
71. NICE-SUGAR Study Investigators, Finfer S., Liu B., et al. Hypoglycemia and risk of death in critically ill patients. NEngl J Med 2012, 367(12):1108-1118.
72. Ramos M., Khalpey Z., Lipsitz S., et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008, 248(4):585-591.
73. Ata A., Lee J., Bestle S.L., et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 2010, 145(9):858-864.
74. Sugerman H.J., Kellum J.M., Reines H.D., et al. Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 1996, 171:80-84.
75. Puzziferri N., Austrheim-Smith I., Wolfe B., et al. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg 2006, 243(2):181-188.
76. Sauerland S., Korenkov M., Kleinen T. Obesity is a risk factor for recurrence after incisional hernia repair. Hernia 2004, 8:42-46.
77. Rickard R.F., Hudson D.A. Influence of vascular delay on abdominal wall complications in unipedicled TRAM flap breast reconstruction. Ann Plast Surg 2003, 50(2):138-142.
78. Beck W.C., Holzman M.D., Sharp K.W., et al. Comparative effectiveness of dynamic abdominal sonography for hernia vs computed tomography in the diagnosis of incisional hernia. JAm Coll Surg 2013, 216(3):447-453. [quiz: 510-1].
79. Swenson B.R., Hedrick T.L., Metzger R., et al. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol 2009, 30(10):964-971.
80. Darouiche R.O., Wall M.J., Itani K.M., et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. NEngl J Med 2010, 362(1):18-26.
81. Swenson B.R., Sawyer R.G. Importance of alcohol in skin preparation protocols. Infect Control Hosp Epidemiol 2010, 31(9):977.
82. Tanner J., Norrie P., Melen K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 2011, (11). CD004122.
83. Dumville J.C., McFarlane E., Edwards P., et al. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 2013, (3). CD003949.
84. Edmiston C.E., Okoli O., Graham M.B., et al. Evidence for using chlorhexidine gluconate preoperative cleansing to reduce the risk of surgical site infection. AORN J 2010, 92(5):509-518.
85. Chlebicki M.P., Safdar N., O'Horo J.C., et al. Preoperative chlorhexidine shower or bath for prevention of surgical site infection: a meta-analysis. Am J Infect Control 2013, 41(2):167-173.
86. Bode L.G., Kluytmans J.A., Wertheim H.F., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. NEngl J Med 2010, 362(1):9-17.
87. Kim D.H., Spencer M., Davidson S.M., et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. JBone Joint Surg Am 2010, 92(9):1820-1826.
88. Jose B., Dignon A. Is there a relationship between preoperative shaving (hair removal) and surgical site infection?. JPerioper Pract 2013, 23(1-2):22-25.
89. Justinger C., Moussavian M.R., Schlueter C., et al. Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery 2009, 145(3):330-334.
90. Reid K., Pockney P., Draganic B., et al. Barrier wound protection decreases surgical site infection in open elective colorectal surgery: a randomized clinical trial. Dis Colon Rectum 2010, 53(10):1374-1380.
91. Horiuchi T., Tanishima H., Tamagawa K., et al. Randomized, controlled investigation of the anti-infective properties of the Alexis retractor/protector of incision sites. JTrauma 2007, 62(1):212-215.
92. Flores-Maldonado A., Medina-Escobedo C.E., Rios-Rodriguez H.M., et al. Mild perioperative hypothermia and the risk of wound infection. Arch Med Res 2001, 32(3):227-231.
93. Qadan M., Gardner S.A., Vitale D.S., et al. Hypothermia and surgery: immunologic mechanisms for current practice. Ann Surg 2009, 250(1):134-140.
94. Lehtinen S.J., Onicescu G., Kuhn K.M., et al. Normothermia to prevent surgical site infections after gastrointestinal surgery: holy grail or false idol?. Ann Surg 2010, 252(4):696-704.
95. Fakhry S.M., Montgomery S.C. Peri-operative oxygen and the risk of surgical infection. Surg Infect (Larchmt) 2012, 13(4):228-233.
96. Greif R., Akca O., Horn E.P., Outcomes Research Group, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. NEngl J Med 2000, 342(3):161-167.
97. Belda F.J., Aguilera L., Garcia de la Asuncion J., et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005, 294(16):2035-2042.
98. Meyhoff C.S., Wetterslev J., Jorgensen L.N., et al. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA 2009, 302(14):1543-1550.
99. Al-Niaimi A., Safdar N. Supplemental perioperative oxygen for reducing surgical site infection: a meta-analysis. JEval Clin Pract 2009, 15(2):360-365.
100. Hempel S., Newberry S.J., Maher A.R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012, 307(18):1959-1969.
101. Johnston B.C., Ma S.S., Goldenberg J.Z., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012, 157(12):878-888.
102. Goldenberg J.Z., Ma S.S., Saxton J.D., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013, (5). CD006095.
103. Valkenet K., van de Port I.G., Dronkers J.J., et al. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehabil 2011, 25(2):99-111.